908 Devices Inc. MASS
We take great care to ensure that the data presented and summarized in this overview for 908 Devices Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MASS
View all-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.79MShares$7.42 Million0.05% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.81MShares$4.83 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$4.5 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY1.67MShares$4.45 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.32MShares$3.52 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA581KShares$1.55 Million0.0% of portfolio
-
Tao Capital Management LP San Francisco, CA569KShares$1.51 Million0.97% of portfolio
-
Granahan Investment Management, LLC Waltham, MA523KShares$1.39 Million0.05% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.467KShares$1.24 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.467KShares$1.24 Million0.01% of portfolio
Latest Institutional Activity in MASS
Top Purchases
Top Sells
About MASS
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Insider Transactions at MASS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 03
2025
|
Christopher D. Brown Chief Product Officer |
SELL
Open market or private sale
|
Direct |
7,767
-0.27%
|
$15,534
$2.34 P/Share
|
|
Feb 03
2025
|
Kevin J. Knopp President and CEO |
SELL
Open market or private sale
|
Direct |
16,001
-0.76%
|
$32,002
$2.32 P/Share
|
|
Feb 03
2025
|
Michael S. Turner Chief Legal & Admin Officer |
SELL
Open market or private sale
|
Direct |
9,672
-10.38%
|
$19,344
$2.33 P/Share
|
|
Feb 03
2025
|
Joseph H. Iv Griffith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,236
-2.92%
|
$20,472
$2.34 P/Share
|
|
Feb 01
2025
|
Christopher D. Brown Chief Product Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,436
+0.8%
|
-
|
|
Feb 01
2025
|
Kevin J. Knopp President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,709
+1.96%
|
-
|
|
Feb 01
2025
|
Michael S. Turner Chief Legal & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,170
+26.13%
|
-
|
|
Feb 01
2025
|
Joseph H. Iv Griffith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,669
+7.38%
|
-
|
|
Dec 19
2024
|
Christopher D. Brown Chief Product Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,131
+5.5%
|
$55,131
$1.58 P/Share
|
|
Dec 13
2024
|
Kevin J. Knopp President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
158,044
+11.04%
|
$158,044
$1.67 P/Share
|
|
Aug 07
2024
|
Christopher D. Brown Chief Product Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,328
+0.71%
|
$6,328
$1.58 P/Share
|
|
Jun 12
2024
|
Marcia Eisenberg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,777
+34.77%
|
-
|
|
Jun 12
2024
|
Fenel M Eloi |
BUY
Exercise of conversion of derivative security
|
Direct |
7,777
+33.48%
|
-
|
|
Jun 12
2024
|
Jeffrey P. George |
BUY
Exercise of conversion of derivative security
|
Direct |
7,777
+33.48%
|
-
|
|
Jun 12
2024
|
Anthony Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
7,777
+31.82%
|
-
|
|
Jun 12
2024
|
E Kevin Hrusovsky |
BUY
Exercise of conversion of derivative security
|
Direct |
7,777
+5.26%
|
-
|
|
Jun 12
2024
|
Mark Spoto |
BUY
Exercise of conversion of derivative security
|
Direct |
7,777
+12.8%
|
-
|
|
Jun 12
2024
|
Keith Crandell |
BUY
Exercise of conversion of derivative security
|
Direct |
7,777
+35.83%
|
-
|
|
Jun 07
2024
|
Marcia Eisenberg |
BUY
Exercise of conversion of derivative security
|
Direct |
682
+9.1%
|
-
|
|
May 13
2024
|
Kevin J. Knopp President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+1.93%
|
$60,000
$6.42 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 454K shares |
|---|---|
| Open market or private purchase | 50K shares |
| Open market or private sale | 43.7K shares |
|---|